Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs function by mimicking the natural actions of GLP-1, a hormone produced by the gut https://reganulyu981057.blogdomago.com/37664625/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes